ATRIN PHARMACEUTICALS Email Format
Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees
Atrin Pharmaceuticals is a small pharmaceutical manufacturing company based in Ambler, Pennsylvania. Its work centers on discovering and developing therapeutics that target the DNA damage response pathway in cancer, pursuing synthetic lethality as a mechanism to affect tumor cells. The organization operates with a compact team within the oncology research space. In May 2022, Atrin Pharmaceuticals was acquired by Aprea Therapeutics. Earlier, in 2020, Atrin partnered with Signum-Health and Yes International to develop diagnostic tools intended to improve identification of cancer patients who would most benefit from DDR-targeted therapies. These collaborations illustrate a history of external partnerships in oncology diagnostics and research.